Cargando…
Detection of Embryonic Trisomy 21 in the First Trimester Using Maternal Plasma Cell-Free RNA
Prenatal trisomy 21 (T21) screening commonly involves testing a maternal blood sample for fetal DNA aneuploidy. It is reliable but poses a cost barrier to universal screening. We hypothesized maternal plasma RNA screening might provide similar reliability but at a lower cost. Discovery experiments u...
Autores principales: | Weiner, Carl P., Weiss, Mark L., Zhou, Helen, Syngelaki, Argyro, Nicolaides, Kypros H., Dong, Yafeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221829/ https://www.ncbi.nlm.nih.gov/pubmed/35741220 http://dx.doi.org/10.3390/diagnostics12061410 |
Ejemplares similares
-
Maternal Plasma RNA in First Trimester Nullipara for the Prediction of Spontaneous Preterm Birth ≤ 32 Weeks: Validation Study
por: Weiner, Carl P., et al.
Publicado: (2023) -
First-Trimester Screening for Gestational Diabetes Mellitus in Twin Pregnancies
por: Buerger, Olga, et al.
Publicado: (2021) -
Competing Risks Model for Prediction of Small for Gestational Age Neonates and the Role of Second Trimester Soluble Fms-like Tyrosine Kinase-1
por: Nowacka, Urszula, et al.
Publicado: (2021) -
IONA test for first‐trimester detection of trisomies 21, 18 and 13
por: Poon, L. C., et al.
Publicado: (2015) -
Non-Invasive Epigenetic Detection of Fetal Trisomy 21 in First Trimester Maternal Plasma
por: Lim, Ji Hyae, et al.
Publicado: (2011)